Focus on Patients
-
The DEI Dilemma: Separate Teams Or Embedded Methods?
8/28/2024
Denise Bronner, PH.D. examines the advantages and drawbacks of separate, dedicated DEI teams and diversity roles embedded across functional areas.
-
Summing Up The FDA's Long-Anticipated Draft Guidance On Diversity Action Plans
8/26/2024
Life sciences attorney Marylana Saadeh Helou summarizes the FDA's draft guidance on Diversity Action Plans (DAPs).
-
Individual Participant Data Return Solutions And Strategies
8/22/2024
Paula Boyles, external clinical trial data-sharing program lead for Pfizer and TransCelerate BioPharma member, shares the benefits of and strategies for individual patient data return (iPDR).
-
Operationalizing A Diversity Action Plan That Makes An Impact
8/19/2024
In part two of this series on creating a diversity action plan (DAP), Elevate Advocacy's Devra Densmore shares a detailed plan for creating a DAP that meets FDA expectations.
-
The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now?
8/16/2024
After the recent FDA rejection of MDMA-assisted therapy for PTSD, psychedelic drug developers and mental health experts alike are asking (and answering), "Where do we go now?"
-
Creating More Equitable Clinical Trials With Health Systems Science
8/15/2024
Belmont University Center for Health Systems Science Chair Douglas P. Slakey, MD, MPH explains how using health systems science to inform clinical trial design, implementation, and interpretation is crucial for achieving more equitable and effective patient outcomes.
-
Diversity Action Plan (DAP): Creating An Ecosystem For Success
8/12/2024
In part one of this two-part series, Elevate Advocacy Founder Devra Densmore explores how to create an ecosystem in which a successful diversity action plan (DAP) can be written and executed.
-
Want More Diverse Enrollment? Slow Down And Listen To Patients
8/2/2024
Getting more diverse patients enrolled in clinical trials isn't an easy task, but Teri Crumb, MSN, RN, CCRC says it could be as simple as taking the time to understand and then meet patients' needs.
-
5 Drivers Of Patient Financial Toxicity — And 10 Tips To Address Them
7/30/2024
Clinical research administrator Tina Bowdish points to five causes of financial toxicity for patients participating in clinical trials and offers 10 ways to address them.
-
4 Tips For Diverse Recruiting In Dermatologic Clinical Trials
6/17/2024
Diverse patient recruitment in dermatologic clinical trials is imperative for addressing health disparities and advancing equitable care. Alain Michon, MD defines those disparities, describes why they exist, and offers four tips for offering underserved patients better care.